1
|
Philpot P, Graumuller F, Melchiorre N, Prahaladan V, Takada X, Chandran S, Guillermo M, Dickler D, Aghai ZH, Das P, Bhandari V. Hyperoxia-Induced miR-195 Causes Bronchopulmonary Dysplasia in Neonatal Mice. Biomedicines 2024; 12:1208. [PMID: 38927415 PMCID: PMC11201213 DOI: 10.3390/biomedicines12061208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2024] [Revised: 05/21/2024] [Accepted: 05/24/2024] [Indexed: 06/28/2024] Open
Abstract
Background: Exposure to hyperoxia is an important factor in the development of bronchopulmonary dysplasia (BPD) in preterm newborns. MicroRNAs (miRs) have been implicated in the pathogenesis of BPD and provide a potential therapeutic target. Methods: This study was conducted utilizing a postnatal animal model of experimental hyperoxia-induced murine BPD to investigate the expression and function of miR-195 as well as its molecular signaling targets within developing mouse lung tissue. Results: miR-195 expression levels increased in response to hyperoxia in male and female lungs, with the most significant elevation occurring in 40% O2 (mild) and 60% O2 (moderate) BPD. The inhibition of miR-195 improved pulmonary morphology in the hyperoxia-induced BPD model in male and female mice with females showing more resistance to injury and better recovery of alveolar chord length, septal thickness, and radial alveolar count. Additionally, we reveal miR-195-dependent signaling pathways involved in BPD and identify PH domain leucine-rich repeat protein phosphatase 2 (PHLPP2) as a novel specific target protein of miR-195. Conclusions: Our data demonstrate that high levels of miR-195 in neonatal lungs cause the exacerbation of hyperoxia-induced experimental BPD while its inhibition results in amelioration. This finding suggests a therapeutic potential of miR-195 inhibition in preventing BPD.
Collapse
Affiliation(s)
- Patrick Philpot
- Division of Neonatology, Department of Pediatrics, Thomas Jefferson University, Nemours, Philadelphia, PA 19107, USA; (P.P.); (Z.H.A.)
- Division of Neonatology, Department of Pediatrics, Drexel University College of Medicine, Philadelphia, PA 19102, USA; (V.P.); (P.D.)
| | - Fred Graumuller
- Division of Neonatology, The Children’s Regional Hospital at Cooper, Cooper Medical School of Rowan University, Camden, NJ 08103, USA; (F.G.); (N.M.); (X.T.); (S.C.); (M.G.); (D.D.)
| | - Nicole Melchiorre
- Division of Neonatology, The Children’s Regional Hospital at Cooper, Cooper Medical School of Rowan University, Camden, NJ 08103, USA; (F.G.); (N.M.); (X.T.); (S.C.); (M.G.); (D.D.)
| | - Varsha Prahaladan
- Division of Neonatology, Department of Pediatrics, Drexel University College of Medicine, Philadelphia, PA 19102, USA; (V.P.); (P.D.)
- Division of Neonatology, The Children’s Regional Hospital at Cooper, Cooper Medical School of Rowan University, Camden, NJ 08103, USA; (F.G.); (N.M.); (X.T.); (S.C.); (M.G.); (D.D.)
| | - Xander Takada
- Division of Neonatology, The Children’s Regional Hospital at Cooper, Cooper Medical School of Rowan University, Camden, NJ 08103, USA; (F.G.); (N.M.); (X.T.); (S.C.); (M.G.); (D.D.)
| | - Srinarmadha Chandran
- Division of Neonatology, The Children’s Regional Hospital at Cooper, Cooper Medical School of Rowan University, Camden, NJ 08103, USA; (F.G.); (N.M.); (X.T.); (S.C.); (M.G.); (D.D.)
| | - Melissa Guillermo
- Division of Neonatology, The Children’s Regional Hospital at Cooper, Cooper Medical School of Rowan University, Camden, NJ 08103, USA; (F.G.); (N.M.); (X.T.); (S.C.); (M.G.); (D.D.)
| | - David Dickler
- Division of Neonatology, The Children’s Regional Hospital at Cooper, Cooper Medical School of Rowan University, Camden, NJ 08103, USA; (F.G.); (N.M.); (X.T.); (S.C.); (M.G.); (D.D.)
| | - Zubair H. Aghai
- Division of Neonatology, Department of Pediatrics, Thomas Jefferson University, Nemours, Philadelphia, PA 19107, USA; (P.P.); (Z.H.A.)
| | - Pragnya Das
- Division of Neonatology, Department of Pediatrics, Drexel University College of Medicine, Philadelphia, PA 19102, USA; (V.P.); (P.D.)
- Division of Neonatology, The Children’s Regional Hospital at Cooper, Cooper Medical School of Rowan University, Camden, NJ 08103, USA; (F.G.); (N.M.); (X.T.); (S.C.); (M.G.); (D.D.)
| | - Vineet Bhandari
- Division of Neonatology, Department of Pediatrics, Drexel University College of Medicine, Philadelphia, PA 19102, USA; (V.P.); (P.D.)
- Division of Neonatology, The Children’s Regional Hospital at Cooper, Cooper Medical School of Rowan University, Camden, NJ 08103, USA; (F.G.); (N.M.); (X.T.); (S.C.); (M.G.); (D.D.)
| |
Collapse
|
2
|
Liu Z, Zhang Y, Li D, Fu J. Cellular senescence in chronic lung diseases from newborns to the elderly: An update literature review. Biomed Pharmacother 2024; 173:116463. [PMID: 38503240 DOI: 10.1016/j.biopha.2024.116463] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2023] [Revised: 03/11/2024] [Accepted: 03/15/2024] [Indexed: 03/21/2024] Open
Abstract
The role of cellular senescence in age-related diseases has been fully recognized. In various age-related-chronic lung diseases, the function of alveolar epithelial cells (AECs) is impaired and alveolar regeneration disorders, especially in bronchopulmonary dysplasia,pulmonary fibrosis (PF), chronic obstructive pulmonary disease (COPD), cancer, etc. Except for age-related-chronic lung diseases, an increasing number of studies are exploring the role of cellular senescence in developmental chronic lung diseases, which typically originate in childhood and even in the neonatal period. This review provides an overview of cellular senescence and lung diseases from newborns to the elderly, attempting to draw attention to the relationship between cellular senescence and developmental lung diseases.
Collapse
Affiliation(s)
- Ziyun Liu
- Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, PR China
| | - Yiqi Zhang
- Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, PR China
| | - Danni Li
- Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, PR China.
| | - Jianhua Fu
- Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, PR China.
| |
Collapse
|
3
|
Dennery PA, Yao H. Emerging role of cellular senescence in normal lung development and perinatal lung injury. CHINESE MEDICAL JOURNAL PULMONARY AND CRITICAL CARE MEDICINE 2024; 2:10-16. [PMID: 38567372 PMCID: PMC10987039 DOI: 10.1016/j.pccm.2024.01.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 04/04/2024]
Abstract
Cellular senescence is a status of irreversible growth arrest, which can be triggered by the p53/p21cip1 and p16INK4/Rb pathways via intrinsic and external factors. Senescent cells are typically enlarged and flattened, and characterized by numerous molecular features. The latter consists of increased surfaceome, increased residual lysosomal activity at pH 6.0 (manifested by increased activity of senescence-associated beta-galactosidase [SA-β-gal]), senescence-associated mitochondrial dysfunction, cytoplasmic chromatin fragment, nuclear lamin b1 exclusion, telomere-associated foci, and the senescence-associated secretory phenotype. These features vary depending on the stressor leading to senescence and the type of senescence. Cellular senescence plays pivotal roles in organismal aging and in the pathogenesis of aging-related diseases. Interestingly, senescence can also both promote and inhibit wound healing processes. We recently report that senescence as a programmed process contributes to normal lung development. Lung senescence is also observed in Down Syndrome, as well as in premature infants with bronchopulmonary dysplasia and in a hyperoxia-induced rodent model of this disease. Furthermore, this senescence results in neonatal lung injury. In this review, we briefly discuss the molecular features of senescence. We then focus on the emerging role of senescence in normal lung development and in the pathogenesis of bronchopulmonary dysplasia as well as putative signaling pathways driving senescence. Finally, we discuss potential therapeutic approaches targeting senescent cells to prevent perinatal lung diseases.
Collapse
Affiliation(s)
- Phyllis A. Dennery
- Department of Molecular Biology, Cell Biology & Biochemistry, Division of Biology and Medicine, Brown University, Providence, RI 02912, USA
- Department of Pediatrics, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA
| | - Hongwei Yao
- Department of Molecular Biology, Cell Biology & Biochemistry, Division of Biology and Medicine, Brown University, Providence, RI 02912, USA
| |
Collapse
|